managing treatment toxicities when developing novel agents for mpns
Published 2 years ago • 92 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
1:43
the changing treatment landscape of pnh: novel agents and combinations
-
1:01
advancements in cml: improving treatment-free remission and novel agents
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
8:03
5 herbs for lung health, clearing mucus, copd, and killing viruses
-
7:25
how to manage toxicities from immune checkpoint inhibitors?
-
16:09
aplastic anemia bone marrow atg homeopathy treatment bleeding hemoglobin platelets increases indore
-
1:34
managing adverse events with novel therapies in lower-risk mds
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
3:21
looking beyond jak inhibitors: novel targeted therapies and strategies for mpn treatment
-
1:17
novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclax
-
2:37
reducing the risk of cardiovascular toxicities when treating hematological malignancies
-
1:17
exciting novel treatments being developed for mds
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
1:17
novel agents to improve outcomes for patients with multiple myeloma in the salvage setting
-
1:54
navigating regulatory challenges in developing and approving therapies for rare lymphomas
-
2:06
managing relapsed all: the role of novel cellular therapies & importance of conditioning regimens
-
0:57
novel therapeutic strategies in all
-
1:51
current treatment strategies for crs and insights into other car-related toxicities
-
1:08
insights into disease-modifying agents being explored in mpns